Opioid receptor genes inactivated in mice: the highlights.
about
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effectsCurrent research on opioid receptor function.Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activationAnti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonistDual action of epidermal growth factor: extracellular signal-stimulated nuclear-cytoplasmic export and coordinated translation of selected messenger RNAAgonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.Kappa opioid receptor contributes to EGF-stimulated neurite extension in developmentModulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens.Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.Opioid receptor desensitization: mechanisms and its link to toleranceDmt and opioid peptides: a potent alliance.Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cordReward processing by the opioid system in the brain.The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system.Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profileThe endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.Ligand-directed signalling within the opioid receptor family.Panic, suffocation false alarms, separation anxiety and endogenous opioids.Opioid receptors: distinct roles in mood disorders.Gender, variation in opioid receptor genes and sensitivity to experimental pain.Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mδ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling.The kappa-opiate receptor impacts the pathophysiology and behavior of substance use.A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.Biased agonism: An emerging paradigm in GPCR drug discovery.Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.Decreased [3H]naloxone Binding in the Dentate Gyrus of Cloninger Type 1 Anxiety-Prone Alcoholics: A Postmortem Whole-Hemisphere Autoradiography Study.Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons.Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1α and opioid receptors in experimental rats.Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
P2860
Q24543997-F4867BE6-6D16-45AF-AE02-6B1E2F627C09Q27693220-3DC7394A-98BD-4BF9-B16D-D1CDF15264DFQ28179746-BD8868C4-A6D0-4F04-9195-D6EF4EB2C5F6Q28652289-B5579ED1-9A1B-48AC-A95A-8AFB744FD983Q33643711-3CBCF4B0-CF09-4988-A2DC-7278085C940AQ33708526-EA477A09-E8E9-4261-8CF4-8302332450C3Q33733621-D7F3CC92-5647-4A78-9678-30FD1F96FF89Q33788059-F3166FFF-BCB1-42C3-96AC-E796224D9CC7Q33815047-A7EB77F1-41A9-42D1-967F-BFDF252E3A13Q33923583-F499F800-CC96-4F7C-A0BC-BE360540EAB5Q34729984-76332DAF-3AB7-4C55-972D-F4F4AE043DF2Q35136105-EF80DB4B-9210-4F0B-AFDA-D33D0A1357D7Q35552722-94C51556-B078-4F0C-9B9A-5D88460BD028Q35786247-64AE1961-2B6B-49C2-AC9C-93F75759D0F0Q35974778-AD056612-EF6A-48A9-A022-C5AAE47B0931Q36015414-7DCCE558-A60F-47AB-93BD-2713B410CDA6Q36020861-3E070425-1CB1-4B75-82B5-BDE1CEFA97F5Q36110480-9AA9428D-AF92-4ECE-B7A8-C9CBC44A7525Q36174184-02BA974C-B8DE-45B5-9445-5ADB12813154Q36382935-9C79ABAC-69D5-4280-8214-36B3CF11F4CAQ36574138-F13876D7-8068-433A-B83F-2F6F4FDF02BFQ36675341-C15AA3B2-8FDD-4A06-BD1B-30AE7550D18BQ36794010-FADB11C1-6901-40BB-BB03-B0638C4501C3Q37153933-F6921702-0CF2-49E2-B3D4-D8BA1962EE80Q37317909-17764057-F760-41A7-A86A-2F1E71C5078CQ37453223-71AB6709-1614-4BB6-8A45-4A9C9AB464A2Q37483673-7527039F-0D37-4FEC-AC4B-FA263ED2DFF5Q37582266-1CA5E51A-0CE4-4708-BA14-B2063779C257Q38440471-7041B78C-78B6-4E43-8BD0-4A6B7D3F4ABAQ38743944-E9E4C5C5-B025-4A46-87CF-0EAC8E457EA0Q38859899-09B05B3D-5EDE-4728-BE5C-A60DA29E3F31Q41610569-35801A7A-23F7-4548-8D7F-E7B8A023DCEFQ41902104-7C2677CB-9DD9-4727-A8C0-AA5F4B1AAD97Q42076848-BBE56054-91FE-492C-B687-65D62816C543Q42452889-1264EDE8-04DF-4E5B-BE16-8AB14FFFE9DDQ44341273-896822CB-D7CF-448E-89B4-E37836E4397EQ44344324-6A3B0022-C460-47C7-9035-5F52394522DDQ44346409-D7FD10BD-64C7-441F-97B5-0D91BE00A134Q46709181-2C92322B-C870-4843-B97C-012E33F2EB0BQ48307161-8D2E7AF3-0597-42F2-90F0-00E9CB193B02
P2860
Opioid receptor genes inactivated in mice: the highlights.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Opioid receptor genes inactivated in mice: the highlights.
@ast
Opioid receptor genes inactivated in mice: the highlights.
@en
Opioid receptor genes inactivated in mice: the highlights.
@nl
type
label
Opioid receptor genes inactivated in mice: the highlights.
@ast
Opioid receptor genes inactivated in mice: the highlights.
@en
Opioid receptor genes inactivated in mice: the highlights.
@nl
prefLabel
Opioid receptor genes inactivated in mice: the highlights.
@ast
Opioid receptor genes inactivated in mice: the highlights.
@en
Opioid receptor genes inactivated in mice: the highlights.
@nl
P356
P1433
P1476
Opioid receptor genes inactivated in mice: the highlights
@en
P2093
B L Kieffer
P356
10.1054/NPEP.2002.0900
P577
2002-04-01T00:00:00Z